Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas.
Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas. Researchers have published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas.